Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
China · Delayed Price · Currency is CNY 15.60
-0.19 (-1.20%)
Jun 2, 2026, 3:00 PM CST
SHA:603896 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,093 | 3,842 | 4,205 | 6,391 | 7,821 | 8,835 | |
Market Cap Growth | -22.77% | -8.63% | -34.21% | -18.28% | -11.47% | 75.22% |
Enterprise Value | 2,601 | 3,336 | 3,633 | 5,674 | 7,115 | 8,199 |
Last Close Price | 15.60 | 19.38 | 20.96 | 31.35 | 38.17 | 42.59 |
PE Ratio | - | 211.40 | 24.11 | 25.12 | 28.16 | 43.99 |
Forward PE | - | 22.02 | 13.91 | 20.94 | 23.38 | 39.93 |
PS Ratio | 4.95 | 6.00 | 5.96 | 8.15 | 9.43 | 11.52 |
PB Ratio | 1.35 | 1.70 | 1.84 | 2.94 | 4.10 | 5.45 |
P/TBV Ratio | 1.60 | 2.02 | 2.17 | 3.44 | 4.28 | 5.75 |
P/FCF Ratio | - | - | - | - | 49.29 | 65.41 |
P/OCF Ratio | 16.42 | 16.85 | 19.56 | 20.29 | 22.92 | 29.78 |
EV/Sales Ratio | 4.16 | 5.21 | 5.15 | 7.23 | 8.58 | 10.69 |
EV/EBITDA Ratio | 17.20 | 20.74 | 19.17 | 21.20 | 24.06 | 35.12 |
EV/EBIT Ratio | 43.24 | 38.67 | 29.94 | 28.22 | 29.84 | 44.49 |
EV/FCF Ratio | -39.49 | - | - | - | 44.84 | 60.70 |
Debt / Equity Ratio | 0.25 | 0.27 | 0.26 | 0.35 | 0.37 | 0.07 |
Debt / EBITDA Ratio | 3.73 | 3.50 | 2.90 | 2.70 | 2.33 | 0.45 |
Debt / FCF Ratio | - | - | - | - | 4.45 | 0.79 |
Net Debt / Equity Ratio | -0.21 | -0.23 | -0.27 | -0.35 | -0.44 | -0.43 |
Net Debt / EBITDA Ratio | -3.62 | -3.23 | -3.22 | -2.82 | -2.87 | -3.00 |
Net Debt / FCF Ratio | 7.49 | 11.51 | 2.09 | 7.60 | -5.35 | -5.19 |
Asset Turnover | 0.20 | 0.20 | 0.22 | 0.26 | 0.34 | 0.42 |
Inventory Turnover | 0.67 | 0.70 | 0.83 | 0.89 | 1.05 | 1.27 |
Quick Ratio | 2.58 | 2.26 | 3.35 | 2.77 | 3.55 | 4.66 |
Current Ratio | 3.13 | 2.69 | 3.87 | 3.09 | 3.90 | 5.25 |
Return on Equity (ROE) | -0.50% | 0.80% | 7.82% | 12.48% | 15.74% | 13.60% |
Return on Assets (ROA) | 1.19% | 1.68% | 2.41% | 4.17% | 6.19% | 6.29% |
Return on Invested Capital (ROIC) | -0.54% | 0.90% | 7.84% | 16.24% | 24.10% | 21.43% |
Return on Capital Employed (ROCE) | 2.20% | 3.20% | 4.40% | 7.80% | 10.00% | 10.50% |
Earnings Yield | -0.37% | 0.47% | 4.15% | 3.98% | 3.55% | 2.27% |
FCF Yield | -2.13% | -1.18% | -6.95% | -1.56% | 2.03% | 1.53% |
Dividend Yield | 1.73% | - | 1.29% | 1.24% | 1.15% | 0.73% |
Payout Ratio | - | 327.37% | 47.58% | 36.46% | 22.00% | 23.66% |
Buyback Yield / Dilution | -0.12% | -1.87% | -1.26% | -0.77% | -1.56% | -3.77% |
Total Shareholder Return | 1.61% | -1.87% | 0.03% | 0.47% | -0.41% | -3.04% |